Multiple sclerosis drug linked to many more cases of leukemia
Posted Nov 17 2009 10:20pm
Risk of Leukemia with Multiple Sclerosis Drug Higher Than Thought
reported April 30, 2009
This morning at the American Academy of Neurology’s conference in Seattle, a report was released reporting that there is a significantly increased risk of leukemia from the drug mitoxantrone (Novantrone) in patients with progressive forms of multiple sclerosis (MS).
Novantrone has always had significant health risks. When patients receive a dosage increase they must undergo regular cardiac monitoring due to the risk of cardiotoxicity and the threat of permanent heart damage.